Zegalogue (DASIGLUCAGON)
Zegalogue (DASIGLUCAGON) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Zegalogue; Generic name: DASIGLUCAGON; Drug class: Antihypoglycemic Agent [EPC].
| Brand name | Zegalogue |
|---|---|
| Generic name | DASIGLUCAGON |
| Drug class | Antihypoglycemic Agent [EPC] |
| Manufacturer | Novo Nordisk |
| Used for | 1 INDICATIONS AND USAGE ZEGALOGUE ® is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above. ZEGALOGUE is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION • ZEGALOGUE autoinjector and prefilled syringe are for subcutaneous injection only. ( 2.1 ) • The dose in adults and pediatric patients aged 6 years and older is 0.6 mg. ( 2.2 ) • Administer ZEGALOGUE according to the printed instructions on the protective case label and the Instructions For Use. ( 2.1 ) • Visually inspect ZEGALOGUE prior to administration. The solution should appear clear, colorless, and free from particles. If the solution is discolored or contains |
| Active ingredient(s) | DASIGLUCAGON |
| Route | SUBCUTANEOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14704879-872c-4967-8779-04a3bbdfb4e6 |